Cardio Diagnostics Holdings, Inc. Depreciation
Cardio Diagnostics Holdings, Inc. (CDIO) reported Depreciation of $44.28 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. depreciation for the quarter ending 2026-06-30 was $44.28K, a 17.20% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. depreciation for the quarter ending 2026-03-31 was $44.24K, a 17.48% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. depreciation for the quarter ending 2025-12-31 was $44.22K, a 18.12% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. depreciation for the quarter ending 2025-09-30 was $40.40K, a 9.90% increase year-over-year.
- Cardio Diagnostics Holdings, Inc. depreciation for fiscal 2025 was $160.06K, a 40.68% increase from fiscal 2024.
- Cardio Diagnostics Holdings, Inc. depreciation for fiscal 2024 was $113.78K, a 2902.03% increase from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. depreciation for fiscal 2023 was $3.79K.
- Cardio Diagnostics Holdings, Inc. depreciation for fiscal 2022 was $0.00.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $44.28K 10-Q · filed 2026-08-07 | $88.52K 10-Q · filed 2026-08-07 | $132.74K derived: sum of 3 quarters · filed 2026-08-07 | $173.15K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $44.24K 10-Q · filed 2026-05-15 | $88.46K derived: sum of 2 quarters · filed 2026-05-15 | $128.86K derived: sum of 3 quarters · filed 2026-05-15 | $166.65K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $44.22K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $84.62K derived: sum of 2 quarters · filed 2026-03-13 | $122.41K derived: sum of 3 quarters · filed 2026-08-07 | $160.06K 10-K · filed 2026-03-13 |
| 2025-09-30 | $40.40K 10-Q · filed 2025-11-12 | $78.19K derived: sum of 2 quarters · filed 2026-08-07 | $115.84K 10-Q · filed 2025-11-12 | $153.28K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $37.78K 10-Q · filed 2026-08-07 | $75.44K 10-Q · filed 2026-08-07 | $112.88K derived: sum of 3 quarters · filed 2026-08-07 | $149.64K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $37.66K 10-Q · filed 2026-05-15 | $75.09K derived: sum of 2 quarters · filed 2026-05-15 | $111.85K derived: sum of 3 quarters · filed 2026-05-15 | $147.85K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $37.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $74.20K derived: sum of 2 quarters · filed 2026-03-13 | $110.19K derived: sum of 3 quarters · filed 2026-03-13 | $113.78K 10-K · filed 2026-03-13 |
| 2024-09-30 | $36.76K 10-Q · filed 2025-11-12 | $72.75K derived: sum of 2 quarters · filed 2025-11-12 | $76.34K 10-Q · filed 2025-11-12 | $78.75K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $35.99K 10-Q · filed 2025-08-14 | $39.58K 10-Q · filed 2025-08-14 | $41.99K derived: sum of 3 quarters · filed 2025-08-14 | $43.37K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $3.59K 10-Q · filed 2025-05-15 | $6.00K derived: sum of 2 quarters · filed 2025-05-15 | $7.38K derived: sum of 3 quarters · filed 2025-05-15 | $7.38K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $2.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $3.79K derived: sum of 2 quarters · filed 2025-03-20 | $3.79K derived: sum of 3 quarters · filed 2025-03-20 | $3.79K 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.38K 10-Q · filed 2024-11-13 | $1.38K derived: sum of 2 quarters · filed 2024-11-13 | $1.38K 10-Q · filed 2024-11-13 | $1.38K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |